Sort
53,477 grants matching “addiction”
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
$2,169,367Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2022 · DA
NIDA Clinical Trials Network: Greater New York Node
$2,165,120John P Rotrosen · New York University School Of Medicine · UG1 · FY2018 · DA
Psychotherapy Development Research Center
$2,163,000Kathleen M Carroll · Yale University · P50 · FY2010 · DA
Center for Research on Improving the Treatment of Drug Abuse
$2,159,703Charles P O'Brien · University Of Pennsylvania · P60 · FY2011 · DA
Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors
$2,158,500John K Hewitt · University Of Colorado · P60 · FY2011 · DA
The short and long-term dynamics of opioid/stimulant use: Mixed methods to informoverdose prevention and treatment related to polysubstance use
$2,158,107Becky Lynn Genberg · Johns Hopkins University · R01 · FY2022 · DA
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
$2,157,311William R Sellers · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Discovery and validation of a novel orphan GPCR as a target for therapeutic intervention in neuropathic pain
$2,156,764Daniela Salvemini · Saint Louis University · R01 · FY2019 · NS
Characterization of neuronal ensembles activated during drug-induced behavior
$2,156,045Bruce Hope · National Institute On Drug Abuse · ZIA · FY2017 · DA
The Ohio Valley Node of the Clinical Trials Network
$2,152,484T John Winhusen · University Of Cincinnati · UG1 · FY2024 · DA
Assessment,Treatment, and Pharmacological Interventions in Alcoholic Patients
$2,152,158Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
Brain-penetrant GPR88 agonists as novel therapeutics for opioid abuse
$2,150,978Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · DA
Psychotherapy Development Research Center
$2,150,553Kathleen M Carroll · Yale University · P50 · FY2011 · DA
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$2,149,542Stephen A Spector · University Of California, San Diego · UM1 · FY2023 · AI
Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical program.
$2,149,117Hugh William Alsop · Kinoxis Therapeutics Pty Ltd · UH3 · FY2023 · DA
NIDA CENTER FOR GENETIC STUDIES. SEPTEMBER 17, 2019 - SEPTEMBER 16, 2020. N01DA-18-7797. TASK ORDER 4.
$2,149,000Jay Tischfield · Rutgers, The State Univ Of N.J. · N01 · FY2019 · DA
Injectable naltrexone 2-month depot formulations
$2,148,235Kinam Park · Purdue University · UG3 · FY2020 · DA
Hypothalamic neuronal circuits controlling survival behaviors
$2,148,061Yeka Aponte · National Institute On Drug Abuse · ZIA · FY2025 · DA
Biology of Neuroendocrine Peptides
$2,145,749Marc R Montminy · Salk Institute For Biological Studies · P01 · FY2014 · DK
Biology of Neuroendocrine Peptides
$2,145,749Marc R Montminy · Salk Institute For Biological Studies · P01 · FY2011 · DK
Biology of Neuroendocrine Peptides
$2,145,749Marc R Montminy · Salk Institute For Biological Studies · P01 · FY2012 · DK
Multimodal preclinical imaging studies of decisional determinants of drug vs non-drug choice
$2,144,367Charles Bradberry · National Institute On Drug Abuse · ZIA · FY2020 · DA
Center for Research on Improving the Treatment of Drug Abuse
$2,144,106Charles P O'Brien · University Of Pennsylvania · P60 · FY2008 · DA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,143,865Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA
Interdisciplinary Center of Excellence for the Study of Pain and Sensory Function
$2,142,323Ian D Meng · University Of New England · P20 · FY2019 · GM